Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty

Aim:Gonadotropin-releasing hormone analogs (GnRHa) are standard medical treatments for precocious puberty. Studies on their side effects in adults have shown that these drugs can cause changes in electrocardiography (ECG), along with some cardiovascular effects; however, the number of studies on chi...

Full description

Bibliographic Details
Main Authors: Eren Er, Aysun Ata, Ali Orgun
Format: Article
Language:English
Published: Galenos Yayinevi 2023-09-01
Series:Journal of Pediatric Research
Subjects:
Online Access: http://jpedres.org/archives/archive-detail/article-preview/evaluation-of-electrocardiographic-changes-in-girl/62081
_version_ 1797685889662451712
author Eren Er
Aysun Ata
Ali Orgun
author_facet Eren Er
Aysun Ata
Ali Orgun
author_sort Eren Er
collection DOAJ
description Aim:Gonadotropin-releasing hormone analogs (GnRHa) are standard medical treatments for precocious puberty. Studies on their side effects in adults have shown that these drugs can cause changes in electrocardiography (ECG), along with some cardiovascular effects; however, the number of studies on children is limited. This study investigated the effects of these drugs on ECG parameters in children diagnosed with central precocious puberty (CPP).Materials and Methods:This prospective study included 44 girls who were initiated GnRHa treatment and diagnosed with CPP. ECG was performed before treatment and repeated after 6 months of treatment.Results:The mean age of the children was 9.13±1.55 years. Leuprolide acetate (3.75 mg IM) was administered to all of the patients following the standard protocol. A comparison of the pre-treatment and 6-month ECG parameters revealed a prolonged QT interval after treatment, with a statistically significant difference (p<0.001). There were no significant differences in the pre- and post-treatment values of PR, QRS, QT interval, QTc interval, QT dispersion, or QTc dispersion (p>0.05).Conclusion:Despite a significant increase in QT interval on ECG with GnRHa compared to pre-treatment ECGs, this increase was attributed to a variability in heart rate. Even if regular ECG monitoring is considered after initiation of GnRHa treatment, they are believed to be safe drugs in children.
first_indexed 2024-03-12T00:57:50Z
format Article
id doaj.art-21132c227dec4c33b54ba08b41b77d44
institution Directory Open Access Journal
issn 2147-9445
2587-2478
language English
last_indexed 2024-03-12T00:57:50Z
publishDate 2023-09-01
publisher Galenos Yayinevi
record_format Article
series Journal of Pediatric Research
spelling doaj.art-21132c227dec4c33b54ba08b41b77d442023-09-14T11:14:18ZengGalenos YayineviJournal of Pediatric Research2147-94452587-24782023-09-0110322222710.4274/jpr.galenos.2023.4875313049054Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious PubertyEren Er0Aysun Ata1Ali Orgun2 University of Health Sciences Turkey, İzmir Tepecik Training and Research Hospital, Clinic of Pediatric Endocrinology, İzmir, Turkey Adana City Training and Research Hospital, Clinic of Pediatric Endocrinology, Adana, Turkey Adana City Training and Research Hospital, Clinic of Pediatric Cardiology, Adana, Turkey Aim:Gonadotropin-releasing hormone analogs (GnRHa) are standard medical treatments for precocious puberty. Studies on their side effects in adults have shown that these drugs can cause changes in electrocardiography (ECG), along with some cardiovascular effects; however, the number of studies on children is limited. This study investigated the effects of these drugs on ECG parameters in children diagnosed with central precocious puberty (CPP).Materials and Methods:This prospective study included 44 girls who were initiated GnRHa treatment and diagnosed with CPP. ECG was performed before treatment and repeated after 6 months of treatment.Results:The mean age of the children was 9.13±1.55 years. Leuprolide acetate (3.75 mg IM) was administered to all of the patients following the standard protocol. A comparison of the pre-treatment and 6-month ECG parameters revealed a prolonged QT interval after treatment, with a statistically significant difference (p<0.001). There were no significant differences in the pre- and post-treatment values of PR, QRS, QT interval, QTc interval, QT dispersion, or QTc dispersion (p>0.05).Conclusion:Despite a significant increase in QT interval on ECG with GnRHa compared to pre-treatment ECGs, this increase was attributed to a variability in heart rate. Even if regular ECG monitoring is considered after initiation of GnRHa treatment, they are believed to be safe drugs in children. http://jpedres.org/archives/archive-detail/article-preview/evaluation-of-electrocardiographic-changes-in-girl/62081 ecggnrh agonistprecocious pubertyqtqtcqt dispersionqtc dispersion
spellingShingle Eren Er
Aysun Ata
Ali Orgun
Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
Journal of Pediatric Research
ecg
gnrh agonist
precocious puberty
qt
qtc
qt dispersion
qtc dispersion
title Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
title_full Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
title_fullStr Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
title_full_unstemmed Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
title_short Evaluation of Electrocardiographic Changes in Girls Receiving Gonadotropin-Releasing Hormone Analogs for Precocious Puberty
title_sort evaluation of electrocardiographic changes in girls receiving gonadotropin releasing hormone analogs for precocious puberty
topic ecg
gnrh agonist
precocious puberty
qt
qtc
qt dispersion
qtc dispersion
url http://jpedres.org/archives/archive-detail/article-preview/evaluation-of-electrocardiographic-changes-in-girl/62081
work_keys_str_mv AT erener evaluationofelectrocardiographicchangesingirlsreceivinggonadotropinreleasinghormoneanalogsforprecociouspuberty
AT aysunata evaluationofelectrocardiographicchangesingirlsreceivinggonadotropinreleasinghormoneanalogsforprecociouspuberty
AT aliorgun evaluationofelectrocardiographicchangesingirlsreceivinggonadotropinreleasinghormoneanalogsforprecociouspuberty